Hellenic Institute For The Study Of Sepsis
Clinical trials sponsored by Hellenic Institute For The Study Of Sepsis, explained in plain language.
-
Could blocking a key immune signal help fight sepsis?
Disease control OngoingThis study tests a drug called emapalumab in adults with sepsis who have a specific immune pattern (high interferon-gamma). The drug blocks this signal to see if it helps patients recover faster in the ICU. About 75 people will take part, and the study compares two different dose…
Phase: PHASE2 • Sponsor: Hellenic Institute for the Study of Sepsis • Aim: Disease control
Last updated May 26, 2026 03:56 UTC
-
New test combo could slash unnecessary antibiotics in sepsis
Knowledge-focused OngoingThis study tests whether using rapid diagnostic tests (BCID2, Reveal Rapid AST, and PCT) can help doctors choose the right antibiotics faster for patients with severe infections (sepsis). About 190 adults in Greek ICUs will be randomly assigned to either the new test-guided appro…
Phase: PHASE3 • Sponsor: Hellenic Institute for the Study of Sepsis • Aim: Knowledge-focused
Last updated May 19, 2026 11:59 UTC